Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
Lina Khan, the powerful chair of the Federal Trade Commission, knows her tough-on-antitrust stance displeases some but says ...
FTC seeks clear information on how social media and streaming companies determine which specific ads and other content to ...
None of the companies reported sharing practices that treat teen users' data differently than that of adults, the study found ...
Antitrust regulation isn't just about protecting consumers, Federal Trade Commission Chair Lina Khan said Thursday afternoon ...
It’s been almost a month since the new FTC rule was officially approved, but if you still can’t smell what The Rock-a-Khan is ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Social media companies gather data through tracking technologies used in online advertising and buying information from data ...
Consumers do not understand how much privacy they are giving up, largely to facilitate targeted advertising, the Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback